What You Should Know
- Photon has secured $16 million in Series A funding led by Healthier Capital, with participation from Notation, Flare Capital, and Evidenced.
- The platform addresses the “information vacuum” of traditional e-prescribing, where patients choose pharmacies without knowing price, inventory, or convenience.
- Photon utilizes artificial intelligence as an engine to process complex, fragmented data across pharmacy networks and formularies in real time.
- The platform serves as an end-to-end infrastructure, offering modern routing, a pharmacy marketplace, and prior authorization capabilities.
- Since its founding in 2021, Photon has helped millions of patients and is expanding its footprint within major health systems to drive in-house pharmacy utilization.
Electronic prescribing transformed how doctors write prescriptions, but it left the patient in a data vacuum. At the moment of prescribing, patients are often forced to choose a pharmacy on the spot with zero visibility into out-of-pocket costs or whether the medication is even in stock. Photon, an infrastructure leader built for the AI era, has announced $16M in Series A funding to solve this “point-of-care” bottleneck by rebuilding the prescription experience from the ground up.
The problem is rooted in early-2000s infrastructure that was designed simply to move data from point A to point B. Photon replaces this antiquated handoff with a Medical Intelligence Layer that empowers consumers with the same real-time transparency they expect in every other digital transaction. By integrating at the point of prescribing, Photon allows patients to see pricing and availability before the prescription is ever sent, reducing the downstream friction of transfers, phone calls, and abandoned fills.
AI as the Engine for Marketplace Transparency
Artificial intelligence is not a “feature” for Photon; it is the mechanical necessity that makes a hard infrastructure problem solvable. The platform leverages LLMs and agentic workflows to parse through fragmented benefit structures and pharmacy networks to translate complex data into actionable choices for the patient.
This AI-native approach enables:
- Modern Routing: Orchestrating prescriptions across a vast network of retail and home delivery partners.
- Consumer Marketplace: Surfacing real-time stock information to ensure patients don’t arrive at a pharmacy only to find their medication is unavailable.
- Health System Integration: Turning the prescription into a patient engagement touchpoint that drives visibility into in-house pharmacy competitiveness and patient retention.
From D2C Roots to Enterprise Health Systems
Photon began its journey in the direct-to-consumer (D2C) digital health space, powering the infrastructure for some of the fastest-growing health brands. This foundation in high-velocity, patient-first prescribing has made Photon a compelling partner for traditional health systems seeking to modernize their pharmacy workflows.
The new capital will be used to expand engineering and commercial teams, deepening integrations across health systems and platform partners. Otto Sipe, Photon founder and CEO, noted that the company is scaling at a juncture where consumer demand for transparency and healthcare affordability have reached a “boiling point”.
